{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:52:41Z","timestamp":1790707961947,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Overactive bladder (OAB) is one of the most common complications in patients with multiple sclerosis (MS). Choosing the effective treatment is very important in improving their quality of life (QOL). Therefore, the aim of this study was to compare solifenacin (SS) and posterior tibial nerve stimulation (PTNS) treatment effects in the MS Patients with OAB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In total, 70 MS patients suffering from OAB enrolled in this clinical trial study. Patients with a score of at least 3 according to the OAB questionnaire were randomly divided into two groups (35 patients in each group). In one group, patients received SS (5 mg daily for 4 weeks and 10 mg\/day for another 8 weeks) and in a second group, patients were treated by PTNS (12 weekly session, 30 min).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean (SD) age of patients participating in this study was 39.82 (9.088) and 42.41 (9.175) years for the SS group and the PTNS group, respectively. Patients in both groups showed statistically significant improvements in urinary incontinence, micturition, and daytime frequency (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Patients in the SS group had a better response for urinary incontinence after 12 weeks compared to the PTNS group. Also, patients in the SS group reported higher satisfaction and less daytime frequency compared to the PTNS group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SS and PTNS were effective for improving the OAB symptoms in patients with MS. However, patients demonstrated a better experience with SS in terms of daytime frequency, urinary incontinence, and treatment satisfaction rate.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1107886","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T06:36:15Z","timestamp":1676961375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Solifenacin versus posterior tibial nerve stimulation for overactive bladder in patients with multiple sclerosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Nastaran","family":"Majdinasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Orakifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Kouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Shamsaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Seyedtabib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2700227","DOI":"10.1155\/2022\/2700227","article-title":"Posterior tibial nerve stimulation for overactive bladder: Mechanism, classification, and management outlines.","volume":"2022","author":"Al-Danakh","year":"2022","journal-title":"Parkinsons Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22102215","DOI":"10.1097\/01.ju.0000067446.17576.bd","article-title":"Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.","volume":"169","author":"Amarenco","year":"2003","journal-title":"J. Urol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10072-010-0376-4","article-title":"Cognitive impairment in early stages of multiple sclerosis.","volume":"31","author":"Amato","year":"2010","journal-title":"Neurol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ucl.2010.06.007","article-title":"Neuromodulation and the neurogenic bladder.","volume":"37","author":"Burks","year":"2010","journal-title":"Urol. Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1742-1241.2006.01067.x","article-title":"Solifenacin significantly improves all symptoms of overactive bladder syndrome.","volume":"60","author":"Chapple","year":"2006","journal-title":"Int. J. Clin. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.juro.2010.12.067","article-title":"Current state of nerve stimulation technique for lower urinary tract dysfunction in children.","volume":"185","author":"De Gennaro","year":"2011","journal-title":"J. Urol."},{"key":"B7","first-page":"119","article-title":"Posterior tibial nerve stimulation: is the once-a-week protocol the best option?","volume":"57","author":"Finazzi Agr\u00f2","year":"2005","journal-title":"Minerva Urol. Nefrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.eururo.2006.07.024","article-title":"Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS.","volume":"51","author":"Fjorback","year":"2007","journal-title":"Eur. Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/00365599309180416","article-title":"Traditional acupuncture and electrical stimulation of the posterior tibial nerve: A trial in chronic interstitial cystitis.","volume":"27","author":"Geirsson","year":"1993","journal-title":"Scand. J. Urol. Nephrol."},{"key":"B10","first-page":"1","article-title":"Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy.","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"B11","first-page":"175","article-title":"Multiple sclerosis review.","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Ther."},{"key":"B12","first-page":"685","article-title":"Validity and reliability of the international consultation on incontinence questionnaire-urinary incontinence short form and its correlation with urodynamic findings.","volume":"9","author":"Hajebrahimi","year":"2012","journal-title":"Urol. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis.","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther. Adv. Neurol. Disorder."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7224\/1537-2073.2013-040","article-title":"Lower urinary tract symptom prevalence and management among patients with multiple sclerosis.","volume":"17","author":"Khalaf","year":"2015","journal-title":"Int. J. MS Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0090-4295(00)00727-5","article-title":"Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: A urodynamic-based study.","volume":"56","author":"Klingler","year":"2000","journal-title":"Urology"},{"key":"B16","first-page":"57","article-title":"Urinary tract infections in multiple sclerosis: Under-diagnosed and under-treated? A clinical audit at a large University hospital.","volume":"3","author":"Mahadeva","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nurt.2007.10.063","article-title":"Sacral nerve stimulation: Neuromodulation for voiding dysfunction and pain.","volume":"5","author":"Mayer","year":"2008","journal-title":"Neurotherapeutics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bpobgyn.2005.08.001","article-title":"Female voiding dysfunction.","volume":"19","author":"Olujide","year":"2005","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/9781681089041121090009","article-title":"Pharmacotherapy of multiple sclerosis and treatment strategies.","volume":"9","author":"Ragab","year":"2021","journal-title":"Front. Clin. Drug Res. CNS Neurol. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/luts.12059","article-title":"Reliability and validation of the international consultation on incontinence questionnaire in over active bladder to persian language","volume":"7","author":"Sari Motlagh","year":"2015","journal-title":"Low. Urin. Tract Symptoms"},{"key":"B21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11934-012-0274-9","article-title":"Percutaneous tibial nerve stimulation: A clinically and cost effective addition to the overactive bladder algorithm of care.","volume":"13","author":"Staskin","year":"2012","journal-title":"Curr. Urol. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-018-0857-z","article-title":"The management of lower urinary tract dysfunction in multiple sclerosis.","volume":"18","author":"Tornic","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"834753","DOI":"10.1155\/2011\/834753","article-title":"Solifenacin in multiple sclerosis patients with overactive bladder: A prospective study.","volume":"2011","author":"van Rey","year":"2011","journal-title":"Adv. Urol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1107886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T06:36:24Z","timestamp":1676961384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1107886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":23,"alternative-id":["10.3389\/fnins.2023.1107886"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1107886","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"article-number":"1107886"}}